Security
Akebia Therapeutics, Inc. Common Stock · AKBA
AKBANASDAQCommon stockCurrentCIK 1517022Updated Oct 26, 2026
AKBA price & chart
Loading TradingView…
NASDAQ:AKBA on TradingView ↗About the company
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts.
In the news
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ↗
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) News provided by Akebia Therapeutics, Inc. Jan 02, 2025, 16:05 ET Share this article Share to X Share this article Share to X CAMBRIDGE, Mass. , Jan. 2, 2025 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA ↗
Seeking Alpha
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens ↗
Akebia plans Vafseo price reset after Dec. 31, 2026 TDAPA as VOICE trial posts win odds 1.16 ↗
Akebia Therapeutics, Inc. (AKBA) Q2 2026 Earnings Call Transcript ↗
SEC disclosures
Akebia Therapeutics, Inc. files 8-K: Material Event ↗
Recent filings
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Items 3.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
S-8 filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Show 5 more recent filings
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
144 filing
4 filing
4 filing
Submission of Matters to a Vote of Security Holders
Items 5.07
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 364,152,000Source | 207,142,000Source | 349,658,000Source | 345,595,000Source | 220,196,000Source | 362,520,000Source | 310,185,000Source | 225,477,000Source | 376,565,000Source | 220,670,000Source | 241,703,000Source | 541,799,000Source |
| Property, Plant and Equipment, NetUSD | 1,473,000Source | 2,533,000Source | 1,514,000Source | 1,714,000Source | 2,895,000Source | 956,000Source | 1,904,000Source | 3,265,000Source | 1,222,000Source | 2,200,000Source | 3,629,000Source | — |
| GoodwillUSD | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | 9,011,000Source | — | — | 18,021,000Source | — | — | 27,032,000Source | — | 0Source | 36,042,000Source | — |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 166,444,000Source | 34,019,000Source | 155,548,000Source | 137,308,000Source | 39,499,000Source | 162,644,000Source | 113,374,000Source | 41,961,000Source | 184,844,000Source | 51,870,000Source | 42,925,000Source | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 66,223,000Source | 32,170,000Source | 53,506,000Source | 72,809,000Source | 29,765,000Source | 62,536,000Source | 61,538,000Source | 26,620,000Source | 47,031,000Source | 34,368,000Source | 39,290,000Source | 65,358,000Source |
| Inventory, NetUSD | 18,643,000Source | 20,493,000Source | 13,018,000Source | 16,708,000Source | 23,872,000Source | 12,996,000Source | 19,732,000Source | 25,532,000Source | 15,610,000Source | 16,243,000Source | 15,691,000Source | 41,098,000Source |
| Assets, CurrentUSD | 258,336,000Source | 100,120,000Source | 229,553,000Source | 234,657,000Source | 112,097,000Source | 243,481,000Source | 203,782,000Source | 112,944,000Source | 252,955,000Source | 113,831,000Source | 118,149,000Source | 305,139,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 7,026,000Source | 13,438,000Source | 7,481,000Source | 7,832,000Source | 18,961,000Source | 5,305,000Source | 9,138,000Source | 18,831,000Source | 5,470,000Source | 11,350,000Source | 20,243,000Source | — |
| Operating Lease, Right-of-Use AssetUSD | 4,837,000Source | 9,300,000Source | 5,800,000Source | 5,987,000Source | 10,360,000Source | 2,465,000Source | 7,114,000Source | 11,399,000Source | 3,663,000Source | 8,218,000Source | 12,416,000Source | — |
| Other Assets, NoncurrentUSD | 40,462,000Source | 27,134,000Source | 53,747,000Source | 44,193,000Source | 17,779,000Source | 56,574,000Source | 38,341,000Source | 11,793,000Source | 59,681,000Source | 37,377,000Source | 12,423,000Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 322,560,000Source | 257,544,000Source | 324,640,000Source | 316,371,000Source | 253,950,000Source | 335,145,000Source | 285,604,000Source | 252,735,000Source | 343,955,000Source | 269,855,000Source | 272,287,000Source | 519,221,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — |
| Common Stock, Value, IssuedUSD | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | 2,000Source | — |
| Retained Earnings (Accumulated Deficit)USD | -1,671,461,000Source | -1,655,556,000Source | -1,701,667,000Source | -1,672,001,000Source | -1,635,517,000Source | -1,692,759,000Source | -1,672,248,000Source | -1,626,935,000Source | -1,683,705,000Source | -1,678,360,000Source | -1,608,950,000Source | -1,526,308,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 6,000Source | 6,000Source | 6,000Source | 6,000Source | 6,000Source | 6,000Source | 6,000Source | 6,000Source | 6,000Source | 6,000Source | 6,000Source | — |
| Stockholders' Equity Attributable to ParentUSD | 41,592,000Source | -50,402,000Source | 25,018,000Source | 29,224,000Source | -33,754,000Source | 27,375,000Source | 24,581,000Source | -27,258,000Source | 32,610,000Source | -49,185,000Source | -30,584,000Source | — |
| Additional Paid in Capital, Common StockUSD | 1,713,045,000Source | 1,605,146,000Source | 1,726,677,000Source | 1,701,217,000Source | 1,601,755,000Source | 1,720,126,000Source | 1,696,821,000Source | 1,599,669,000Source | 1,716,307,000Source | 1,629,167,000Source | 1,578,358,000Source | — |
| Liabilities and EquityUSD | 364,152,000Source | 207,142,000Source | 349,658,000Source | 345,595,000Source | 220,196,000Source | 362,520,000Source | 310,185,000Source | 225,477,000Source | 376,565,000Source | 220,670,000Source | 241,703,000Source | 541,799,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 133,379,000Source | 65,709,000Source | 160,865,000Source | 118,717,000Source | 107,300,000Source | 173,884,000Source | 91,227,000Source | 66,487,000Source | 162,938,000Source | 80,914,000Source | 99,870,000Source | 258,497,000Source |
| Operating Lease, Liability, CurrentUSD | 4,936,000Source | 5,289,000Source | 1,006,000Source | 5,629,000Source | 5,179,000Source | 2,127,000Source | 5,514,000Source | 5,071,000Source | 3,548,000Source | 5,400,000Source | 4,491,000Source | — |
| Accounts Payable, CurrentUSD | 10,087,000Source | 13,494,000Source | 9,422,000Source | 11,554,000Source | 10,107,000Source | 8,386,000Source | 12,658,000Source | 11,882,000Source | 21,185,000Source | 15,180,000Source | 14,635,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | 0Source | 4,937,000Source | 4,400,000Source | 671,000Source | 6,299,000Source | — | 2,123,000Source | 7,636,000Source | 0Source | 3,547,000Source | 8,947,000Source | — |
| Other Liabilities, NoncurrentUSD | 5,002,000Source | 4,727,000Source | 562,000Source | 5,355,000Source | 6,557,000Source | 681,000Source | 5,114,000Source | 6,771,000Source | 1,823,000Source | 4,749,000Source | 8,885,000Source | 83,141,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 106,420,000Source | 52,215,000Source | 109,797,000Source | 91,615,000Source | 53,897,000Source | 125,062,000Source | 71,337,000Source | 53,910,000Source | 121,716,000Source | 63,460,000Source | 67,735,000Source | 114,243,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 47,641,000Source | 38,355,000Source | 24,754,000Source | 47,062,000Source | 38,031,000Source | 36,395,000Source | 46,511,000Source | 30,145,000Source | 48,250,000Source | 38,693,000Source | 17,183,000Source | — |
| Long-term Debt, Current MaturitiesUSD | — | 0Source | 24,809,000Source | — | 0Source | 12,495,000Source | — | 0Source | — | 0Source | 17,500,000Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 47,641,000Source | 38,355,000Source | 24,754,000Source | 47,062,000Source | 38,031,000Source | 36,395,000Source | 46,511,000Source | 30,145,000Source | 48,250,000Source | 38,693,000Source | 17,183,000Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 3,668,000Source | 2,187,000Source | 11,283,000Source | 7,775,000Source | 9,317,000Source | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 15,704,000Source | 27,872,000Source | 14,142,000Source | -4,046,000Source | -994,000Source | — |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 2,540,000Source | 4,953,000Source | 23,125,000Source | 28,401,000Source | 2,542,000Source | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -7,792,000Source | -2,234,000Source | 3,082,000Source | -1,364,000Source | -5,244,000Source | — |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -21,207,000Source | -13,587,000Source | 67,992,000Source | -40,659,000Source | -23,384,000Source | — |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -62,000Source | 154,000Source | -7,926,000Source | -33,000Source | 0Source | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 62,000Source | 18,000Source | 291,000Source | 33,000Source | 0Source | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -926,000Source | 74,942,000Source | 72,927,000Source | 49,663,000Source | -25,206,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -22,195,000Source | 61,509,000Source | 132,993,000Source | 8,971,000Source | -48,590,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 168,139,000Source | 35,693,000Source | 157,256,000Source | 138,998,000Source | 164,348,000Source | 115,059,000Source | 186,543,000Source | 53,550,000Source | 44,579,000Source | — |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 6,080,000Source | 5,035,000Source | 6,059,000Source | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 3,221,000Source | 1,646,000Source | 3,226,000Source | 2,676,000Source | 3,668,000Source | 2,187,000Source | 11,283,000Source | 7,775,000Source | 9,317,000Source | — |
| Amortization of Intangible AssetsUSD | — | — | — | 9,000,000Source | — | — | — | 0Source | 0Source | 36,042,000Source | 36,042,000Source | — |
| DepreciationUSD | — | — | — | — | — | — | 328,000Source | 314,000Source | 1,269,000Source | 1,462,000Source | 1,585,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | 0Source | 172,000Source | 172,000Source | — | — | — |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | 0Source | — | — | — | — | 0Source | 0Source | -524,000Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | -517,000Source | 0Source | — |
| GoodwillUSD | — | — | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source | 59,044,000Source |
| Income Tax Expense (Benefit)USD | — | — | 615,000Source | 0Source | 70,000Source | 0Source | 126,000Source | 0Source | 1,624,000Source | — | — | — |
| Inventory Write-downUSD | — | — | — | — | — | — | 3,216,000Source | 163,000Source | 2,505,000Source | 4,208,000Source | 1,600,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | 540,000Source | -20,039,000Source | -8,908,000Source | 247,000Source | -9,054,000Source | 6,112,000Source | -5,345,000Source | -69,410,000Source | -51,925,000Source | — |
| Operating ExpensesUSD | — | — | 44,934,000Source | 35,772,000Source | 45,030,000Source | 38,464,000Source | 45,950,000Source | 36,197,000Source | 173,235,000Source | 147,475,000Source | 166,730,000Source | — |
| Other Nonoperating Income (Expense)USD | — | — | -10,000Source | -17,000Source | -7,000Source | -28,000Source | 3,000Source | 213,000Source | 58,000Source | 94,000Source | 887,000Source | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 20,000Source | 482,000Source | 1,684,000Source | 385,000Source | 1,000Source | — |
| Capitalized Computer Software, Amortization | — | — | — | —Source | — | — | — | — | — | — | — | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | —Source | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 58,766,000Source | 37,428,000Source | 49,128,000Source | 62,472,000Source | 53,544,000Source | 57,336,000Source | 236,196,000Source | 160,180,000Source | 194,623,000Source | 292,484,000Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | 29,094,000Source | 26,516,000Source | 28,171,000Source | 26,555,000Source | 30,436,000Source | 25,742,000Source | 107,480,000Source | 106,545,000Source | 100,233,000Source | 138,601,000Source |
| Operating Income (Loss)USD | — | — | 4,449,000Source | -12,505,000Source | -6,326,000Source | 14,089,000Source | -4,696,000Source | 13,514,000Source | 23,499,000Source | -50,472,000Source | -46,256,000Source | -80,779,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -10,000Source | -17,000Source | -7,000Source | -28,000Source | 3,000Source | 213,000Source | 58,000Source | 94,000Source | 887,000Source | 3,146,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 1,155,000Source | -20,039,000Source | -8,838,000Source | 247,000Source | -8,928,000Source | 6,112,000Source | -3,721,000Source | -69,410,000Source | -51,925,000Source | -94,226,000Source |
| Income Tax Expense (Benefit)USD | — | — | 615,000Source | 0Source | 70,000Source | 0Source | 126,000Source | 0Source | 1,624,000Source | — | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 540,000Source | -20,039,000Source | -8,908,000Source | 247,000Source | -9,054,000Source | 6,112,000Source | -5,345,000Source | -69,410,000Source | -51,925,000Source | -94,226,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 0Source | -0.1Source | -0.03Source | 0Source | -0.03Source | 0.03Source | -0.02Source | -0.33Source | -0.28Source | -0.52Source |
| Earnings Per Share, DilutedUSD per share | — | — | 0Source | -0.1Source | -0.03Source | 0Source | -0.03Source | 0.03Source | -0.02Source | -0.33Source | -0.28Source | -0.52Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 264,786,432Source | 210,348,459Source | 269,602,747Source | 262,565,500Source | 267,046,755Source | 235,497,720Source | 257,157,782Source | 210,946,658Source | 187,465,448Source | 182,782,680Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 274,372,722Source | 210,348,459Source | 269,602,747Source | 271,104,020Source | 267,046,755Source | 241,602,853Source | 257,157,782Source | 210,946,658Source | 187,465,448Source | 182,782,680Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | 9,000,000Source | — | — | — | 0Source | 0Source | 36,042,000Source | 36,042,000Source | 36,043,000Source |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and AmortizationUSD | — | — | 9,383,000Source | 5,150,000Source | 10,424,000Source | 9,919,000Source | 12,290,000Source | 7,625,000Source | 39,462,000Source | 27,135,000Source | 38,107,000Source | 49,526,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 1,624,000Source | 0Source | 0Source | 0Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -3,721,000Source | — | — | — |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | -4,748,000Source | -6,661,000Source | -3,071,000Source | -6,834,000Source | -4,691,000Source | -7,770,000Source | -24,179,000Source | -18,185,000Source | -6,032,000Source | -15,687,000Source |
| Operating ExpensesUSD | — | — | 44,934,000Source | 35,772,000Source | 45,030,000Source | 38,464,000Source | 45,950,000Source | 36,197,000Source | 173,235,000Source | 147,475,000Source | 166,730,000Source | 287,695,000Source |
| Research and Development ExpenseUSD | — | — | 14,944,000Source | 8,487,000Source | 14,059,000Source | 11,013,000Source | 14,807,000Source | 9,754,000Source | 62,359,000Source | 37,652,000Source | 63,079,000Source | 129,986,000Source |
| Capitalized Computer Software, Amortization | — | — | — | —Source | — | — | — | — | — | — | — | — |
| Net Income (Loss) Available to Common Stockholders, Basic | — | — | — | —Source | — | — | — | — | — | — | — | — |
Filing attachments
d908870dex991.htm · 8-K · 2025-03-20
EX-99.1 4 d908870dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Akebia Therapeutics Announces Pricing of Public Offering of Common Stock CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) - Akebia Therapeutics®, Inc. (“Akebia”) (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the pricing of its underwritten public offering (the “Offering”) of 25,000,000 shares of its common stock at a public offering price of $2…
Read attachment ↗